Suite 1400,
New York, NY 10017
Applied Therapeutics is incorporated in Delaware.
Applied Therapeutics was founded in 2016.
Applied Therapeutics is traded on The Nasdaq Global Market under the symbol “APLT.”
Applied Therapeutics’ shares of common stock first started trading on The Nasdaq Global Market on May 13, 2019.
Applied Therapeutics’ transfer agent is Computershare Limited. You can find more information about how to contact Computershare Trust Company at:
Computershare Trust Company, N.A.
P.O Box 505000
Louisville, KY 40233-5000
Phone (US): (877) 373-6374
Phone (non-US): (781) 575-2879
https://www-us.computershare.com/Investor/Contact
03828A 101
Applied Therapeutics’ fiscal year ends on December 31.
Ernst & Young LLP
Shares can be purchased by contacting a securities broker of your choice.
Applied Therapeutics does not currently offer a direct stock purchase plan.
Applied Therapeutics does not currently pay a dividend or offer a dividend reinvestment program.
If the shares are held in your name, you must contact Applied Therapeutics’ transfer agent, Computershare Trust Company, N.A. If your shares are held in street name, you must contact your broker to update your address.
Quarterly and annual reports, as well as other SEC filings, are available under the “Financial Information” section of the “Investors” section of our corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
Please visit the “Investors” section of our corporate website and choose the “Email Alerts” link under the “Investor Resources” section to be added to the Applied Therapeutics distribution list.
For media inquiries, please contact:
media@appliedtherapeutics.com
Argot Partners
Investor Relations
(212) 600-1902
appliedtherapeutics@argotpartners.com